首页 | 本学科首页   官方微博 | 高级检索  
检索        


How we secured a COVID-19 convalescent plasma procurement scheme in Japan
Authors:Mari Terada  Satoshi Kutsuna  Tomiteru Togano  Sho Saito  Noriko Kinoshita  Yumiko Shimanishi  Tetsuya Suzuki  Yusuke Miyazato  Makoto Inada  Takahito Nakamoto  Hidetoshi Nomoto  Satoshi Ide  Mitsuhiro Sato  Kenji Maeda  Akihiro Matsunaga  Masahiro Satake  Keiji Matsubayashi  Hirokazu Tsuno  Makiko Kojima  Madoka Kuramistu  Kenta Tezuka  Emi Ikebe  Kazu Okuma  Isao Hamaguchi  Katsuyuki Shiratori  Motohiko Sato  Yuiko Kawakami  Kumi Inaba  Saori Igarashi  Reina Yamauchi  Mina Matsumura  Keiko Ishimaru  Bijuan Zhang  Chika Kuge  Maiko Ishihara  Miho Gouda  Keiko Tanaka  Yukihito Ishizaka  Norio Ohmagari
Institution:1. Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan

Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan;2. Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan;3. Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan

Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan;4. Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan

Emerging and Reemerging Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan

Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan;5. Department of Refractory Viral Infections, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan;6. Department of Intractable Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan;7. Japanese Red Cross, Central Blood Institute, Tokyo, Japan;8. Japanese Red Cross, Kanto-Koshin-etsu Block Blood Center, Tokyo, Japan;9. Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan;10. Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan;11. Department of Clinical Engineering, National Center for Global Health and Medicine, Tokyo, Japan;12. Nursing Department, National Center for Global Health and Medicine, Tokyo, Japan;13. Research Institute, National Medical Center for Global Health and Medicine, Tokyo, Japan

Abstract:
Keywords:antibody  blood donation  convalescent plasma  COVID-19  plasmapheresis  SARS-CoV-2
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号